John J. Sperzel III - 24 Feb 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chairman, Chief Executive Officer and President, Director
Signature
/s/ Michael Gibbs, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
24 Feb 2022
Net transactions value
-$63,532
Form type
4
Filing time
28 Feb 2022, 15:00:17 UTC
Previous filing
23 Feb 2022
Next filing
11 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +333,333 333,333 24 Feb 2022 Direct F1
transaction TTOO Common Stock Tax liability $63,532 -141,560 -42% $0.4488 191,773 24 Feb 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -333,333 -33% $0.000000 666,667 24 Feb 2022 Common Stock 333,333 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 141,560 shares of common stock were automatically withheld at vesting to cover required tax withholding.
F3 On February 24, 2021 the reporting person was granted 1,000,000 RSU's that vest in three equal installments commencing on February 24, 2022.

Remarks:

Chairman, Chief Executive Officer and President